RoosterBio Launches a Closed System Extracellular Vesicle Collection Medium Enabling Scalable and Standardized cGMP Manufacturing May 21, 2020
RoosterBio Recognized by MTEC with a Multi-Institution Team “Prototype of the Year” Award to Accelerate Regenerative Medicine April 15, 2020
RoosterBio Partners with Senti Biosciences to Rapidly Translate Gene Circuit Cell Therapy into the Clinic March 20, 2020
First Patient Dosed in Phase I Clinical Trial Using RoosterBio’s Cellular Starting Materials March 4, 2020
Australian Patent Office Grants Patent Covering RoosterBio’s Novel Compositions and Formulations for Ready-to-Print (RTP) Cells September 30, 2019
RoosterBio Closes Final Tranche of Oversubscribed $21.5 Million Series B Raise and Appoints Daniella Kranjac to the Board September 10, 2019
RoosterBio Launches the Only Umbilical Cord hMSC System in the World Designed for Cell Therapy Product Development September 6, 2019
